Abstract
Studies on the pathogenesis of Alzheimer's disease (AD) suggest overproduction of amyloid β (Aβ) may not be the only pathogenic route to AD. Decreased degradation of Aβ is another possible disease mechanism. Neprilysin is a neutral endopeptidase that has been proposed to be the major enzyme responsible for Aβ degradation. Studies have reported correlations between Aβ deposition and neprilysin activity in the human brain. This study shows that intracerebroventricular infusion of thiorphan, a neprilysin inhibitor, raises cortical and cerebrospinal fluid (CSF) Aβ concentrations in rabbits. Rabbits treated with thiorphan for 5 days had levels of CSF and cortical Aβ40 that were 147 and 142% of the control group, respectively. Results for Aβ42 showed a similar trend. The results indicate that age-related decreases of neprilysin could lead to increased brain concentrations of Aβ, plaque formation, and AD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
